Diversity among multidrug-resistant enterococci

Emerging Infectious Diseases

Volumn 4, Issue 1, 1998, Pages 37-47

  Murray, Barbara E ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIINFECTIVE AGENT; AZITHROMYCIN; BETA LACTAMASE; CEPHALOSPORIN DERIVATIVE; CLARITHROMYCIN; CLAVULANIC ACID; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; MINOCYCLINE; PENICILLIN G; PENICILLINASE; PHEROMONE; SPECTINOMYCIN; SULBACTAM; TAZOBACTAM; TETRACYCLINE; TOBRAMYCIN; VANCOMYCIN;

BACTERIAL CELL WALL; BACTERIAL COLONIZATION; BACTERICIDAL ACTIVITY; BACTERIUM CONJUGATION; BIODIVERSITY; ENTEROCOCCUS; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PLASMID; REVIEW; TRANSPOSON;

EID: 0031852684     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0401.980106     Document Type: Review

References (75)

1. Murray BE. The life and times of the enterococcus. Clin Microbiol Rev 1990;3:46-65.
2. Moellering RC Jr. Emergence of enterococcus as a significant pathogen. Clin Infect Dis 1992;14:1173-8.
3. Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infection. Am J Med 1991;91(Suppl 3B):72S-75S.
4. Hodges TL, Zighelboim-Daum S, Eliopoulos GM, Wennersten C, Moellering RC Jr. Antimicrobial susceptibility changes in Enterococcus faecalis following various penicillin exposure regimens. Antimicrob Agents Chemother 1992;36:121-5.
5. Zervos MJ, Schaberg DS. Reversal of the in vitro susceptibility of enterococci to trimethoprim-sulfamethoxazole by folinic acid. Antimicrob Agents Chemother 1985;28:446-8.
6. Najjar A, Murray BE. Failure to demonstrate a consistent in vitro bactericidal effect of trimethoprim-sulfamethoxazole against enterococci. Antimicrob Agents Chemother 1987;31:808-10.
7. Chenoweth CE, Robinson KA, Schaberg DR. Efficacy of ampicillin versus trimethprim-sulfamethoxazole in a mouse model of lethal enterococcal peritonitis. Antimicrob Agents Chemother 1990;34:1800-2.
8. Grayson ML, Thauvin-Eliopoulos C, Eliopoulos GM, Yao JDC, DeAngelis DV, Walton L, et al. Failure of trimethoprim-sulfamethoxazole therapy in experimental enterococcal endocarditis. Antimicrob Agents Chemother 1990;34:1792-4.
9. Clewell DB, Keith EW. Sex pheromones and plasmid transfer in Enterococcus faecalis. Plasmid 1989;21:175-84.
10. Clewell DB. Plasmids, drug resistance, and gene transfer in the genus Streptococcus. Microbiol Rev 1981;45:409-36.
11. Clewell DB. Conjugative transposons and the dissemination of antibiotic resistance in streptococci. Annu Rev Microbiol 1986;40:635-59.
12. Roberts MC. Characterization of the Tet M determinants in urogenital and respiratory bacteria. Antimicrob Agents Chemother 1990;34:476-8.
13. Roberts MC, Hillier SL. Genetic basis of tetracycline resistance in urogenital bacteria. Antimicrob Agents Chemother 1990;34:261-4.
14. Quintiliani R Jr, Courvalin P. Characterization of Tn1547, a composite transposon flanked by the IS16 and IS256-like elements, that confers vancomycin resistance in Enterococcus faecalis BM4281. Gene 1996;172:1-8.
15. Ferretti JJ, Gilmore KS, Courvalin P. Nucleotide sequence analysis of the gene specifying the bifunctional 6′-aminoglycoside acetyltransferase 2″-aminoglycoside phosphotransferase enzyme in Streptococcus faecalis and identification and cloning of gene regions specifying the two activities. J Bacteriol 1986;167:631-8.
16. Carlier C, Courvalin P. Emergence of 4′,4″-aminoglycoside nucleotidyltransferase in enterococci. Antimicrob Agents Chemother 1990;34:1565-9.
17. Chow JW, Zervos MJ, Lerner SA, Thal LA, Donabedian SM, Jaworski DD, et al. A novel gentamicin resistance gene in Enterococcus. Antimicrob Agents Chemother 1997;41:511-4.
18. Murray BE. β-lactamase-producing enterococci. Antimicrob Agents Chemother 1992;36:2355-9.
19. Murray BE, Singh KV, Markowitz SM, Lopardo HA, Patterson JE, Zervos MJ, et al. Evidence for clonal spread of a single strain of ß-lactamase-producing Enterococcus faecalis to six hospitals in five states. J Infect Dis 1991;163:780-5.
20. Rhinehart E, Smith NE, Wennersten C, Gorss E, Freeman J, Eliopoulos GM, et al. Rapid dissemination of ß-lactamase-producing, aminoglycoside-resistant Enterococcus faecalis among patients and staff on an infant-toddler surgical ward. N Engl J Med 1990;323:1814-8.
21. Wells VD, Wong ES, Murray BE, Goudron PE, Williams DS, Markowitz DM. Infections due to beta-lactamase-producing, high-level gentamicin-resistant Enterococcus faecalis. Ann Intern Med 1992;116:285-92.
22. Grayson ML, Eliopoulos GM, Wennersten CB, Ruoff KL, de Girolami PC, Ferraro M-J, Moellering, RC Jr. Increasing resistance to ß-lactam antibiotics among clinical isolates of Enterococcus faecium: a 22-year review at one institution. Antimicrob Agents Chemother 1991;35:2180-4.
23. Fontana R, Ligozzi M, Pittaluga F, Satta G. Intrinsic penicillin resistance in enterococci. Microbial Drug Resist 1996;2:209-13.
24. Rice LB, Carias LL, Rudin SB, Donskey CJ. Abstract #LB-17 Transferable ampicillin resistance in Enterococcus faecium and linkage of ampicillin and vancomycin-resistance determinants [abstract]. In program of the 37th ICAAC Program Addendum; 1997 Sep 28-Oct1; Toronto, Ontario, Canada.
25. Perichon B, Reynolds P, Courvalin P. VanD-type glycopeptide-resistant Enterococcus faecium BM4339. Antimicrob Agents Chemother 1997;41:2016-8.
26. Derlot E, Courvalin P. Mechanisms and implications of glycopeptide resistance in enterococci. Am J Med 1991;91(Suppl 3B):82S-5S.
27. Arthur M, Molinas C, Bugg TDH, Wright GD, Walsh CT, Courvalin P. Evidence for in vivo incorporation of D-lactate into peptidoglycan precursors of vancomycin-resistant enterococci. Antimicrob Agents Chemother 1992;36:867-9.
28. Dutka-Malen S, Molinas C, Arthur M, Courvalin P. Sequence of the vanC gene of Enterococcus gallinarum BM4174 encoding a D-alanine:D-alanine ligase-related protein necessary for vancomycin resistance. Gene 1992;112:53-8.
29. Navarro F, Courvalin P. Analysis of genes encoding D-alanine-D-alanine ligase-related enzymes in Enterococcus casseliflavus and Enterococcus flavescens. Antimicrob Agents Chemother 1994;38:1788-93.
30. Billot-Klein D, Gutmann L, Sable S, Guittet E, van Heijenoort J. Modification of peptidoglycan precursors is a common feature of the low-level vancomycin-resistant VANB-type enterococcus D366 and of the naturally glycopeptide-resistant species Lactobacillus casei, Pediococcus pentosaceus, Leuconostoc mesenteroides, and Enterococcus gallinarum. J Bacteriol 1994;176:2398-405.
31. Moellering RC Jr, Wennersten C, Medrek T, Weinberg AN. 1971. Prevalence of high-level resistance to aminoglycosides in clinical isolates of enterococci. Antimicrobial agents and chemotherapy -1970. Washington: American Society for Microbiology; 1971. p. 335-40.
32. Watanakunakorn C. The prevalence of high-level aminoglycoside resistance among enterococci isolated from blood cultures during 1980-1988. J Antimicrob Chemother 1989;24:63-8.
33. Phillips I, King A, Gransden WR, Eykyn SJ. The antibiotic sensitivity of bacteria isolated from the blood of patients in St. Thomas' Hospital, 1969-1988. J Antimicrob Chemother 1990;25:59-80.
34. Zervos MJ, Dembinski S, Mikesell T, Schaberg DR. High-level resistance to gentamicin in Streptococcus faecalis: risk factors and evidence for exogenous acquisition of infection. J Infect Dis 1986;153:1075-83.
35. Eliopoulos GM, Wennersten C, Zighelboim-Daum S, Reiszner E, Goldmann D, Moellering RC Jr. High-level resistance to gentamicin in clinical isolates of Streptococcus (Enterococcus) faecium. Antimicrob Agents Chemother 1988;32:1528-32.
36. Murray BE, Singh KV, Heath JD, Sharma BR, Weinstock GM. Comparison of genomic DNAs of different enterococcal isolates using restriction endonucleases with infrequent recognition sites. J Clin Microbiol 1990;28:2059-63.
37. Zervos MJ, Mikesell TS, Schaberg DR. Heterogeneity of plasmids determining high-level resistance to gentamicin in clinical isolates of Streptococcus faecalis. Antimicrob Agents Chemother 1986;30:78-81.
38. Hodel-Christian SL, Murray BE. Characterization of the gentamicin resistance transposon Tn5281 from Enterococcus faecalis and comparison to staphylococcal transposons Tn4001 and Tn4031. Antimicrob Agents Chemother 1991;35:1147-52.
39. Hodel-Christian SL, Smith M, Zscheck KZ, Murray BE. 1991. Comparison of a gentamicin resistance transposon and a beta-lactamase gene from enterococci to those from staphylococci. In: Dunny GM, Cleary PP, McKay LL, editors. Genetics and molecular biology of streptococci, lactococci, and enterococci. Washington: American Society for Microbiology; 1991. p. 54-8.
40. Thai LA, Chow JW, Clewell DB, Zervos MJ. Tn924, a chromosome-borne transposon encoding high-level gentamicin resistance in Enterococcus faecalis. Antimicrob Agents Chemother 1994;38:1152-6.
41. Rice LB, Carias LL, Marshall SH, Bonafede ME. 1996. Sequences found on staphylococcal ß-lactamase plasmids integrated into the chromosome of Enterococcus faecalis CH116. Plasmid 1996;35:81-90.
42. Seetulsingh PS, Tomayko JF, Coudron PE, Markowitz SM, Skinner C, Singh KV, Murray BE. Chromosomal DNA restriction endonuclease digestion patterns of ß-lactamase-producing Enterococcus faecalis isolates collected from a single hospital over a 7-year period. J Clin Microbiol 1996;34:1892-6.
43. Tomayko JF, Murray BE. Analysis of Enterococcus faecalis isolates from intercontinental sources by multilocus enzyme electrophoresis and pulsed-field gel electrophoresis. J Clin Microbiol 1995;33:2903-7.
44. Coudron PE, Markowitz SM, Wong ES. Isolation of a ß-lactamase-producing, aminoglycoside-resistant strain of Enterococcus faecium. Antimicrob Agents Chemother 1992;36:1125-6.
45. Patterson JE, Singh KV, Murray BE. Epidemiology of an endemic strain of ß-lactamase-producing Enterococcus faecalis. J Clin Microbiol 1991;29:2513-6.
46. Handwerger S, Perlman DC, Altarac D, McAuliffe V. Concomitant high-level vancomycin and penicillin resistance in clinical isolates of enterocoeci. Clin Infect Dis 1992;14:655-61.
47. Miranda AG, Singh KV, Murray BE. DNA fingerprinting of Enterococcus faecium by pulsed-field gel electrophoresis may be a useful epidemiologic tool. J Clin Microbiol 1991;29:2752-7.
48. Handwerger S, Skoble J. Identification of chromosomal mobile element conferring high-level vancomycin resistance in Enterococcus faecium. Antimicrob Agents Chemother 1995;39:2446-53.
49. Handwerger S, Skoble J, Discotto LF, Pucci MJ. Heterogeneity of the vanA gene cluster in clinical isolates of enterococci from the Northeastern United States. Antimicrob Agents Chemother 1995;39:362-8.
50. van den Bogaard AE, Jensen LB, Stobberingh EE. Vancomycin-resistant enterococci in turkeys and farmers. N Engl J Med 1997;337:1558-9.
51. Power EGM, Abdulla YH, Talsania HG, Spice W, Aathithan S, French GL. vanA genes in vancomycin-resistant clinical isolates of Oerskovia turbata and Arcanobacterium (Corynebacterium) haemolyticum. J Antimicrob Chemother 1995;36:595-606.
52. Poyart C, Pierre C, Quesne G, Pron B, Berche P, Trieu-Cuot P. Emergence of vancomycin resistance in the genus Streptococcus: characterization of a vanB transferable determinant in Streptococcus bovis. Antimicrob Agents Chemother 1997;41:24-9.
53. Biavasco F, Miele A, Vignaroli C, Manso E, Lupid R, Varaldo PE. Genotypic characterization of a nosocomial outbreak of VanA Enterococcus faecalis. Microb Drug Resist 1996;2:231-7.
54. Boyce JM, Opal SM, Chow JW, Zervos MJ, Potter-Bynoe G, Sherman CB, et al. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol 1994;32:1148-53.
55. Handwerger S, Raucher B, Altarac D, Monka J, Marchione S, Singh KV, et al. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin and gentamicin. Clin Infect Dis 1993;16:750-5.
56. Livornese LL Jr, Dias S, Samel C, Romanowski B, Taylor S, May P, et al. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med 1992;117:112-6.
57. Moreno F, Grota P, Crisp C, Magnon K, Melcher GP, Jorgensen JH, Patterson JE. Clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium during its emergence in a city in southern Texas. Clin Infect Dis 1995;21:1234-7.
58. Perlada DE, Smulian AG, Cushion MT. Molecular epidemiology and antibiotic susceptibility of enterococci in Cincinnati, Ohio: a prospective citywide survey. J Clin Microbiol 1997;35:2342-7.
59. Chow JW, Kuritza A, Shlaes DM, Green M, Sahm DF, Zervos MJ. Clonal spread of vancomycin-resistant Enterococcus faecium between patients in three hosptials in two states. J Clin Microbiol 1993;31:1609-11.
60. Clark NC, Cooksey RC, Hill BC, Swenson JM, Tenover FC. Characterization of glycopeptide-resistant enterococci from U.S. hospitals. Antimicrob Agents Chemother 1993;37:2311-7.
61. Sader HS, Pfaller MA, Tenover FC, Hollis RJ, Jones RN. Evaluation and characterization of multiresistant Enterococcus faecium from 12 U.S. medical centers. J Clin Microbiol 1994;32:2840-2.
62. Boyle JF, Soumakis SA, Rendo A, Herrington JA, Gianarkis DG, Thurberg BE, Painter BG. Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci. J Clin Microbiol 1993;31:1280-5.
63. Morris JG Jr, Shay DK, Hebden JN, McCarter RJ Jr, Perdue BE, Jarvis W, et al. Enterococci resistant to multiple antimicrobial agents, including vancomycin. Ann Intern Med 1995;123:250-9.
64. Bingen EH, Denamur E, Lambert-Zechovsky NY, Elion J. Evidence for the genetic unrelatedness of nosocomial vancomycin-resistant Enterococcus faecium strains in a pediatric hospital. J Clin Microbiol 1991;29:1888-92.
65. Plessis P, Lamy T, Donnio PY, Autuly F, Grulois I, LePrise PY, Avril JL. Epidemiologic analysis of glycopeptide-resistant Enterococcus strains in neutropenic patients receiving prolonged vancomycin administration. Eur J Clin Microbiol Infect Dis 1995;14:959-63.
66. Jordens JZ, Bates J, Griffiths DT. Faecal carriage and nosocomial spread of vancomycin-resistant Enterococcus faecium. J Antimicrob Chemother 1994;34:515-28.
67. Klare I, Heier H, Claus H, Bohme G, Marin S, Seltmann G, et al. Enterococcus faecium strains with vanA-mediated high-level glycopeptide resistance isolated from animal foodstuffs and fecal samples of humans in the community. Microbial Drug Resist 1995;3:265-72.
68. Van der Auwera P, Pensart N, Korten V, Murray BE, Leclercq R. Influence of oral glycopeptides on the fecal flora of human volunteers: selection of highly-glycopeptide-resistant enterococci. J Infect Dis 1995;173:1129-36.
69. Aarestrup FM, Ahrens P, Madsen M, Pallesen LV, Poulsen RL, Westh H. Glycopeptide susceptibility among Danish Enterococcus faecium and Enterococcus faecalis isolates of animal and human origin and PCR identification of genes within the VanA cluster. Antimicrob Agents Chemother 1996;40:1938-40.
70. Bates J, Jordens Z, Selkon JB. Evidence for an animal origin of vancomycin-resistant enterococci [letter]. Lancet 1993;342:490.
71. Klare I, Heier H, Claus H, Reissbrodt R, Witte W. vanA-mediated high-level glycopeptide resistance in Enterococcus faecium from animal husbandry. FEMS Microbiol Lett 1995;125:165-72.
72. Schouten MA, Voss A, Hoogkamp-Korstanje JAA. VRE and meat. Lancet 1997;349:1258.
73. Coque TM, Tomayko JF, Ricke SC, Okhuysen PO, Murray BE. Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States. Antimicrob Agents Chemother 1996;40:2605-9.
74. Kjerulf A, Pallesen L, Westh H. Vancomycin-resistant enterococci at a large university hospital in Denmark. APMIS 1996;104:475-9.
75. Klare I, Heier H, Claus H, Witte W. Environmental strains of Enterococcus faecium with inducible high-level resistance to glycopeptides. FEMS Microbiol Lett 1993;106:23-30.